Brazil Antiemetics Drugs Market Size & Outlook, 2023-2030
Brazil antiemetics drugs market, 2018-2030 (US$M)
Related Markets
Brazil antiemetics drugs market highlights
- The Brazil antiemetics drugs market generated a revenue of USD 171.9 million in 2023 and is expected to reach USD 252.4 million by 2030.
- The Brazil market is expected to grow at a CAGR of 5.6% from 2024 to 2030.
- In terms of segment, serotonin-receptor antagonists was the largest revenue generating drug type in 2023.
- Serotonin-Receptor Antagonists is the most lucrative drug type segment registering the fastest growth during the forecast period.
Antiemetics drugs market data book summary
| Market revenue in 2023 | USD 171.9 million |
| Market revenue in 2030 | USD 252.4 million |
| Growth rate | 5.6% (CAGR from 2023 to 2030) |
| Largest segment | Serotonin-receptor antagonists |
| Fastest growing segment | Serotonin-Receptor Antagonists |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Serotonin-Receptor Antagonists, Anticholinergics, Dopamine Receptor Antagonists, Neurokinin Receptor Antagonists, Other Drug Types (Antihistamines, Cannabinoids, Glucocorticoids) |
| Key market players worldwide | Pfizer Inc, Cipla Ltd DR, Merck KGaA, Eagle Pharmaceuticals Inc, Johnson & Johnson, GSK PLC ADR, Astellas Pharma Inc, Viatris Inc, Baxter International Inc, Glenmark Pharmaceuticals |
Other key industry trends
- In terms of revenue, Brazil accounted for 2.3% of the global antiemetics drugs market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Latin America, Brazil antiemetics drugs market is projected to lead the regional market in terms of revenue in 2030.
- Argentina is the fastest growing regional market in Latin America and is projected to reach USD 68.6 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Antiemetics Drugs Market Scope
Antiemetics Drugs Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Brazil antiemetics drugs market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to antiemetics drugs market will help companies and investors design strategic landscapes.
Serotonin-receptor antagonists was the largest segment with a revenue share of 29.73% in 2023. Horizon Databook has segmented the Brazil antiemetics drugs market based on serotonin-receptor antagonists, anticholinergics, dopamine receptor antagonists, neurokinin receptor antagonists, other drug types (antihistamines, cannabinoids, glucocorticoids) covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Brazil antiemetics drugs market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Brazil antiemetics drugs market databook
-
Our clientele includes a mix of antiemetics drugs market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil antiemetics drugs market , including forecasts for subscribers. This country databook contains high-level insights into Brazil antiemetics drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Brazil antiemetics drugs market size, by drug type, 2018-2030 (US$M)
Brazil Antiemetics Drugs Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
